OBJECTIVE: Women with Marfan syndrome (MFS) and Loeys-Dietz syndrome (LDS), connective tissue disorders with genetic-predisposition for aortic dissection, have been reported to have a higher rates of preterm birth, but it is unclear whether this is due to iatrogenic or spontaneous causes. The objective of this study was to evaluate the etiology of preterm birth in a cohort of women with MFS and LDS. STUDY DESIGN: We conducted a retrospective observational cohort study of women with a clinical and genetic diagnosis of MFS or LDS who had previously been pregnant. Women were recruited through the National Marfan Foundation website and through the connective tissue clinic at Johns Hopkins Hospital. A woman's first singleton pregnancy was included. Women with incomplete information and those who delivered before 1990 were excluded. The primary outcome was the cause of preterm birth. Women who were diagnosed with MFS/LDS after their pregnancy were also compared to women who received the diagnosis prior to pregnancy in an attempt to identify how medical management changes due to disease diagnosis. RESULTS: A total of 128 pregnancies in women with MFS/LDS were included in the analysis (MFS¼104, LDS¼24). The total preterm rate in this cohort was 48% (N¼61). There was a higher rate of spontaneous preterm birth as compared to iatrogenic preterm birth (87% vs. 13%). Even among women who were not diagnosed with MFS/LDS until after their pregnancy (n¼ 35), there was a high rate of preterm birth, 45% (N¼16), and the majority was spontaneous (94%). As compared to women diagnosed after their pregnancy, those diagnosed prior to their pregnancy were more likely to deliver at an earlier gestational age (36.8 vs. 38.4 weeks, p<0.001), receive general anesthesia (14% vs 3%, p<0.001) and have a cesarean delivery (54% vs 20%, p<0.001). The primary reason for 80% of the cesarean deliveries in the group diagnosed prior to pregnancy was listed as connective tissue disorder. CONCLUSION: In agreement with previous literature, this study highlights that women with MFS and LDS are at higher risk for preterm birth. This risk appears to be driven by spontaneous rather than iatrogenic preterm birth.
909 Methylation profile of circulating cfDNA at term demonstrates relatively low placental contribution to hypomethylated cfDNA 
OBJECTIVE:
The fetal fraction of circulating cell-free DNA (cfDNA) is placental in origin, and is a critical variable in noninvasive prenatal testing (NIPT). Although fetal cfDNA is known to be hypomethylated relative to maternal cfDNA, the methylation profile of circulating cfDNA in maternal plasma has not been well studied. We sought to determine whether hypomethylated cfDNA in maternal plasma: (i) could serve as a proxy for fetal fraction and (ii) was reduced in maternal obesity, as the fetal fraction of circulating cfDNA is known to be decreased in the setting of maternal obesity. STUDY DESIGN: In this prospective pilot study, maternal plasma was collected at admission and 24-48h postpartum (PP) from women admitted for delivery at term. Subjects were enrolled into 4 groups: lean (pre-pregnancy BMI <25 kg/m 2 ) no labor (Lean-NL) (n¼15); lean labor (Lean-L) (n¼18); obese (pre-pregnancy BMI !30 kg/m 2 ) no labor (OB-NL) (n¼16); and obese labor (OB-L) (n¼11). Total cfDNA was isolated and genome-wide methylation levels determined using 0.2x coverage whole-genome bisulfite sequencing (WGBS) in all 60 antepartum (AP) samples and in matching PP samples in w5 patients per study group. Calibration was performed using serial dilutions of fully methylated and unmethylated DNA. RESULTS: Hypomethylated cfDNA fraction was significantly lower in OB vs lean pregnant women (27.0 AE0.5% vs 28.5AE0.3%, p¼0.008). Hypomethylated fraction was significantly higher in AP vs PP samples overall, and when stratified by BMI (Fig 1A/B) , demonstrating that the placenta contributes to hypomethylated cfDNA in maternal circulation. However, matched analyses of 
